Protecting Americans from Unsafe Drugs Act of 2022
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Feb 1, 2022)
Protecting Americans from Unsafe Drugs Act of 2022
This bill expands the authority of the Secretary of the Department of Health and Human Services (HHS) to order the recall of controlled substances to cover all drugs.
Furthermore, the authority to issue such an order may be delegated to the Director of the Center for Drug Evaluation and Research or the Director of the Center for Biologics Evaluation and Research (or an official senior to either director), whereas currently this authority may only be delegated to the Director of the Center for Drug Evaluation and Research or an official senior to such director. (Both centers are located in the Food and Drug Administration within HHS.)
What just happenedFeb 2, 2022
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseFeb 1, 2022
- Feb 2, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 1, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Feb 1, 2022IntroReferralIntro-H
Introduced in House
- Feb 1, 2022IntroReferral1000
Introduced in House